Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Gene Delivery System Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Report Description

Global Gene Delivery System Market: Overview

This report analyzes the current and future scenario of the global the global gene delivery system market. Rise in investments for R&D of novel advanced technologies, increase in incidences of chronic diseases such as cancer, surge in demand for gene therapy, and rise in awareness regarding treatment options expected to drive the market. Gene delivery systems are used to deliver therapeutic drugs to a targeted area. Gene delivery is a procedure to introduce foreign DNA into host cells. The global gene delivery system market is segmented according to type of delivery system, application, route of administration, and geography.

The global gene delivery system market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also offers data analysis of the global market with respect to the segments based on type of delivery system, application, route of administration, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Moreover, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global gene delivery system market.

Global Gene Delivery System Market: Key Segments

Based on delivery system the global gene delivery system market is segmented into viral gene delivery system, non-viral gene delivery system, and combined hybrid system. The viral gene delivery system is further classified into adenovirus system, lentivirus vector, retrovirus vector, adeno-associated virus vector, sendai virus vector, herpes simplex virus vector, and others. The non-viral gene delivery system is further divide into natural organic compounds, physical methods, and chemical methods. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on application, the global gene delivery system market is segmented into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. The oncology segment dominates the market. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

In terms of route of administration, the global gene delivery system market is segmented into oral, injectable, inhalation, transdermal, ocular, nasal, topical, and others. The injectable segment dominates the market. The market size and forecast for each of these segments have been provided for the period between 2015 and 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Gene Delivery System Market: Regional Outlook

Based on geography, the global gene delivery system market has been categorized into five major regions and key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players operating in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the global gene delivery system market are Novartis AG, Amgen Inc., Oxford BioMedia plc, SIBIONO, Shanghai Sunway Biotech Co. Ltd., Pfizer Inc., Bayer AG, Johnson & Johnson Services Inc., Human Stem Cells Institute, and Epeius Biotechnologies Corporation.

The global gene delivery system market has been segmented as follows:

Gene Delivery System Market, by Delivery System

  • Viral Gene Delivery
    • Adenovirus Vector
    • Lentivirus Vector
    • Retrovirus Vector
    • Adeno-associated Virus Vector
    • Sendai Virus Vector
    • Herpes Simplex Virus Vector
    • Others
  • Non-viral Gene Delivery
    • Natural Organic Compounds
    • Physical Methods
    • Chemical Methods
  • Combined Hybrid Delivery System

Gene Delivery System Market, by Application

  • Infectious Diseasess
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

Gene Delivery System Market, by Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

Gene Delivery System Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Israel
    • South Africa
    • Rest of MEA

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote